Previous Article | Next Article ![]()
Infection and Immunity, November 1998, p. 5060-5066, Vol. 66, No. 11
Department of Pathology,
Received 2 March 1998/Returned for modification 2 June
1998/Accepted 10 August 1998
Helicobacter pylori, an important etiologic agent in a
variety of gastroduodenal diseases, produces large amounts of urease as
an essential colonization factor. We have demonstrated previously that
urease is located within the cytoplasm and on the surface of H. pylori both in vivo and in stationary-phase culture. The purpose
of the present study was to assess the relative contributions of
cytoplasmic and surface-localized urease to the ability of H. pylori to survive exposure to acid in the presence of urea. Toward this end, we compared the acid resistance in vitro of H. pylori cells which possessed only cytoplasmic urease to that of bacteria which possessed both cytoplasmic and surface-localized or
extracellular urease. Bacteria with only cytoplasmic urease activity
were generated by using freshly subcultured bacteria or by treating
repeatedly subcultured H. pylori with flurofamide (1 µM),
a potent, but poorly diffusible urease inhibitor. H. pylori with cytoplasmic and surface-located urease activity survived in an
acid environment when 5 mM urea was present. In contrast, H. pylori with only cytoplasmic urease shows significantly reduced survival when exposed to acid in the presence of 5 mM urea. Similarly, Escherichia coli SE5000 expressing H. pylori
urease and the Ni2+ transport protein NixA, which expresses
cytoplasmic urease activity at levels similar to those in wild-type
H. pylori, survived minimally when exposed to acid in the
presence of 5 to 50 mM urea. We conclude that cytoplasmic urease
activity alone is not sufficient (although cytoplasmic urease activity
is likely to be necessary) to allow survival of H. pylori
in acid; the activity of surface-localized urease is essential for
resistance of H. pylori to acid under the assay conditions
used. Therefore, the mechanism whereby urease becomes associated with
the surface of H. pylori, which involves release of the
enzyme from bacteria due to autolysis followed by adsorption of the
enzyme to the surface of intact bacteria ("altruistic autolysis"),
is essential for survival of H. pylori in an acid
environment. The ability of H. pylori to survive exposure to low pH is likely to depend on a combination of both cytoplasmic and
surface-associated urease activities.
Helicobacter pylori is a
spiral, gram-negative bacterium which is the etiologic agent of chronic
superficial gastritis. Infection with H. pylori is strongly
associated with peptic ulcer disease, gastric carcinoma, and gastric
lymphoma (4, 18, 34-36).
An important characteristic of H. pylori is its substantial
urease activity, which appears to be essential for survival and pathogenesis of the bacterium. It is thought that hydrolysis of urea by
urease generates ammonia to counterbalance gastric acidity, presumably
by forming a neutral microenvironment surrounding the bacterium within
the gastric lumen. Supporting this hypothesis, it has been shown that
H. pylori survives at low pH in vitro in the presence of
urea and functional urease activity (25, 27, 28).
Furthermore, isogenic urease-negative mutants of H. pylori and of a related bacterium, Helicobacter mustelae, which
lack urease activity are unable to colonize the gastric mucosa of mice, ferrets, and gnotobiotic piglets (1, 12, 41).
A unique feature of H. pylori is that a significant fraction
of urease, which is found exclusively within the cytoplasm in all other
bacteria and in plants (33), is associated with the outer
membrane both in vitro and in vivo (11, 38). We have shown
that urease becomes associated with the surface of H. pylori by a novel mechanism. Urease is released as a result of autolysis of a
fraction of bacteria and becomes adsorbed to the surface of the
remaining intact bacteria (38). We refer to this process as
"altruistic autolysis," since survival of the population in vitro
and presumably in vivo is dependent upon the occurrence of autolysis
within a fraction of the bacteria (11, 38).
In light of the demonstration that enzymatically active urease is
present both within the cytoplasm and associated with the outer
membrane (8, 19, 38), we sought to determine the relative
contributions of urease activity in these two compartments to the
ability of H. pylori to survive exposure to acid in vitro. In this report, we tested the hypothesis that H. pylori
cells grown in vitro that contain cytoplasmic urease only are sensitive to low pH in the presence of physiologic concentrations of
urea.
Bacterial culture.
H. pylori wild-type strains
N6 and 84-183 (both urease positive) (8, 9) and H. pylori urease-negative mutant strain N6ureB::Km (kindly provided by A. Labigne,
Institut Pasteur, Paris, France) (17) were grown on
Trypticase soy agar containing sheep blood (Remel, Lenexa, Kans.) at
37°C in an atmosphere containing 10% CO2, 5%
O2, and 85% inert gas (N2). Cultures on agar
plates were established in one of two ways, as described previously
(38). Briefly, freshly subcultured (fresh sub) bacteria were
prepared by directly culturing previously frozen stock preparations
onto fresh agar plates immediately from storage vials for 24 h. A
single subculture after 24 h onto another agar plate to increase
the number of bacteria was employed. This agar plate was incubated for
another 24 h before the bacteria were harvested for acid
resistance. In our experience, bacterial autolysis is maximal under
late-logarithmic growth conditions. Therefore, under fresh sub
conditions, we avoided late-logarithmic (typically more than 48 h
of growth) conditions. As determined by electron microscopic
immunolocalization and biochemical analysis (37), in
H. pylori 84-183 grown in this manner, 3 to 7% and 40 to
60% of the urease is surface associated or extracellular at 24 and
72 h, respectively (38). Cultures termed "repeat
sub" were subcultured at least twice at 72-h (which is at the end of the logarithmic growth phase) intervals and then harvested for analysis. In H. pylori 84-183 grown in this manner, 30 to
50% and 70 to 90% of the urease is surface associated or
extracellular at 24 and 72 h, respectively (38).
Proteus mirabilis ATCC 7002 was grown on Trypticase soy agar
containing sheep blood at 37°C in room air. Prior to use, P. mirabilis ATCC 7002 was grown for 2 h in Luria-Bertani broth
containing 50 mM urea to induce urease activity (33).
Escherichia coli SE5000(pHP808/pUEF202) carries the H. pylori urease gene cluster (21) and nixA
encoding the Ni2+ transport protein (31) and
expresses cytoplasmic urease activity at levels similar to those in
wild-type H. pylori. E. coli SE5000(pHP808) carries the
entire urease gene cluster; E. coli SE5000(pUEF202) produces
NixA only (31). E. coli SE5000 and its
transformants were all grown in M-9 minimal medium containing 1 µM
NiCl (31).
Analytical methods.
Urease activity was measured with a
coupled enzyme assay as described previously (8). One unit
of urease activity was defined as the amount capable of hydrolyzing 1 µmol of urea per min. Protein concentrations were measured by the
method of Bradford, as described previously (8). Urease
specific activity was expressed as units of activity per milligram of
protein. Urease specific activity was measured within intact cells and
in bacteria disrupted in a French pressure cell at 20,000 lb/in2 in phosphate-buffered saline (pH 7.2) containing
protease inhibitors (phenylmethylsulfonyl fluoride [0.1 µM] and
leupeptin [1 µM]).
Acid resistance assay.
In general, methods described by
McGowan et al. (27) were used to assess the resistance of
bacteria to acid. Briefly, bacteria were harvested from culture plates
and suspended in normal saline (150 mmol of NaCl per liter [pH 7.2])
to yield a final suspension of approximately 109 CFU/ml.
Bacterial suspensions were then diluted 1:10 (final concentration, 15 mmol of NaCl per liter). The diluted suspensions were incubated in 100 mmol of citric acid-HCl buffer per liter (pH 2) with or without urea (5 to 50 mM) in a microaerobic environment. After 30 min of incubation,
serial dilutions were made in normal saline (pH 7.2), and 0.1 ml of an
appropriate dilution was plated onto blood agar plates and incubated at
37°C for 72 to 96 h in a microaerobic environment to enumerate
viable bacteria (CFU per milliliter). In the case of P. mirabilis and E. coli SE5000, 0.1 ml of appropriate serial dilutions was plated onto blood agar plates maintained at 37°C
in room air. E. coli SE5000(pHP808/pUEF202), E. coli SE5000(pHP808), and E. coli SE5000(pUEF202) were
grown on L plates containing ampicillin (50 µg/ml) and
chloramphenicol (20 µg/ml).
Effect of urease inhibitors.
Flurofamide (kindly provided by
R. Leunk, Procter & Gamble, Cincinnati, Ohio), a potent urease
inhibitor (50% inhibitory concentration [IC50] = 60 nM
[30]), was used at a final concentration of 1 µM
(approximately 17 times the reported IC50). Flurofamide
stock (100 µM) was prepared in water. Acetohydroxamic acid, another urease inhibitor, was used at a final concentration of 7 mM. (The concentration was not 7 µM, as incorrectly reported previously due to
a typographical error [38]; 7 mM is approximately
twice the reported IC50 for H. pylori urease
[30].) Briefly, whole-cell suspensions of H. pylori 84-183 were incubated with the inhibitor for 30 min in
brucella broth containing 10% fetal bovine serum in a microaerobic
environment prior to exposure of the culture to an acidic environment
(100 mmol of citric acid-HCl buffer per liter [pH 2]) for an
additional 30-min incubation. At the end of incubation, serial
dilutions were made to enumerate viable bacteria as described above.
Time course of urease inhibition.
Suspensions of H. pylori 84-183 were incubated for various time intervals in a
microaerobic environment in the presence of flurofamide (1 µM),
acetohydroxamic acid (7 mM), or no inhibitor prior to assessment of
urease activity in whole cells.
Ultrastructural localization of urease antigen in E. coli SE5000(pHP808/pUEF202).
To determine the location of
urease antigen within E. coli SE5000(pHP808/pUEF202), we
employed methods used previously to localize urease and HspB within
H. pylori grown in vitro (38). Briefly, after
growth in M-9 minimal medium containing 1 µM NiCl, bacteria were
pelleted and fixed in 2% paraformaldehyde-0.2%
glutaraldehyde-phosphate-buffered saline (pH 7.2) for 2 h at room
temperature. Bacteria were then embedded in 10% gelatin, which was
solidified on ice. Blocks for ultracryotomy were prepared and
immunolabeled with 10% goat serum in blocking buffer (38).
Immunolabeling with primary affinity-purified, polyclonal antiserum
made in mouse ascites fluid (kindly supplied by H. Kleanthous, Orovax,
Inc., Boston, Mass.) against H. pylori urease (diluted 1:250
to 1:500) was carried out for 2 h. Incubation with secondary
antiserum (goat anti-mouse immunoglobulin G-colloidal gold
[5-nm-diameter particles]; Jackson ImmunoResearch Labs, West Grove,
Pa.), diluted 1:25, was carried out for 1 h. Sections were then
stained with uranyl acetate (38). Controls for specificity of labeling included E. coli SE5000 (which does not carry
urease genes), labeled as described above, and substitution of
preimmune mouse ascites fluid for the primary antibody during
immunolabelling of E. coli SE5000(pHP808/pUEF202).
Effects of exposure to acid on survival of H. pylori.
To
determine the ability of H. pylori to survive exposure to
acid, urease-positive H. pylori strain N6 (72-h repeat sub), urease-negative mutant H. pylori strain
N6ureB::Km (72-h repeat sub), and urease-positive
P. mirabilis strain ATCC 7002 (exposed to 50 mM urea to
induce synthesis of urease) were exposed to acid in the presence or
absence of 5 mM urea. At pH 7 in the absence of urea, all three strains
survived; however, at pH 2 in the absence of urea, survival of H. pylori N6 was reduced 5 logs, while H. pylori
N6ureB::Km and P. mirabilis did not
survive (Fig. 1). At pH 2, in the
presence of 5 mM urea, survival of H. pylori N6 was similar
to that in the presence of saline (pH 7.2) alone (Fig. 1). Addition of
5 mM urea did not promote survival of either the urease-negative
H. pylori mutant N6ureB::Km or P. mirabilis ATCC 7002 (Fig. 1). These results are similar to those
obtained with other H. pylori strains, including 84-183 (25, 27). Since urease localization data were available for
H. pylori 84-183, we chose strain 84-183 for further
studies.
Properties of urease inhibitors.
Flurofamide at a
concentration of 1 µM diffuses slowly, if at all, across the
membranes of H. pylori (38, 39). In contrast, acetohydroxamic acid diffuses rapidly across the membranes of H. pylori (30, 38). To indirectly characterize the time
course of diffusion of flurofamide and acetohydroxamic acid across the membranes of H. pylori, we assessed urease activity after
exposure of H. pylori 84-183 to these urease inhibitors for
up to 150 min. In these experiments, H. pylori 84-183 cells
(72-h fresh sub) were used to partially limit the amount of
surface-adsorbed or extracellular urease (38). After
incubation with 1 µM flurofamide for 10 min at pH 7, urease activity
was reduced to approximately 50% of the initial activity. In contrast,
the freely diffusible inhibitor acetohydroxamic acid inhibited over
95% of urease activity after 10 min (Fig. 2). Continued incubation of
H. pylori whole cells for up to 60 min in the presence of
flurofamide did not result in additional reduction in enzyme activity.
Incubation for an additional 90 min resulted in slightly decreased
urease activity (Fig. 2).
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Helicobacter pylori Containing Only
Cytoplasmic Urease Is Susceptible to Acid
Milwaukee,3 Milwaukee, Wisconsin;
Department of Microbiology and Immunology, University of
Maryland School of Medicine, Baltimore,
Maryland4; and
Department of Cell
Biology and Physiology, Washington University, St. Louis,
Missouri5
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

View larger version (17K):
[in a new window]
FIG. 1.
Effects of exposure to acid (pH 2, 30 min) on survival
of H. pylori N6 (urease positive; 72-h repeat sub), H. pylori N6ureB::Km (urease-negative mutant;
72-h repeat sub), and P. mirabilis ATCC 7002 (urease
positive) in the presence and absence of 5 mM urea. Solid bars
represent H. pylori N6, shaded bars represent H. pylori N6ureB::Km (urease-negative mutant),
and open bars represent P. mirabilis ATCC 7002. In this and
subsequent graphs, bacterial survival is expressed as CFU per
milliliter ± standard error.

View larger version (16K):
[in a new window]
FIG. 2.
Effects of the urease inhibitors flurofamide (FF [1
µM]) and acetohydroxamic acid (AHA [7 mM]) on the time course of
urease activity in whole-cell suspensions of H. pylori
84-183 (72-h fresh sub).
Effect of inhibition of external urease on acid resistance of H. pylori. To characterize the relative contributions of cytoplasmic and surface-associated or extracellular urease to acid resistance, we subjected suspensions of 72-h fresh sub cultures of H. pylori 84-183 to either 1 µM flurofamide or 7 mM acetohydroxamic acid for 30 min. Subsequently, bacteria were exposed to an acidic environment (100 mmol of citric acid-HCl buffer per liter [pH 2]) in the presence or absence of urea. The rationale was that if flurofamide inhibits surface-associated and/or extracellular urease activity exclusively, then the relative contribution of cytoplasmic urease activity to survival of H. pylori in the presence of acid could be assessed. After 30 min of exposure to acetohydroxamic acid (7 mM), which inhibited >90% of urease activity (see Fig. 2), there was a 6-log reduction in bacterial survival (Fig. 3). Preincubation of H. pylori with flurofamide (1 µM) resulted in a 5- to 6-log reduction in bacterial survival upon exposure to acid (Fig. 3). Preincubation of H. pylori with flurofamide (1 µM) followed by 30 min of exposure to sterile saline (pH 7.2) had no adverse effect upon viability, as shown by other investigators (40 [data not shown]).
|
Role of cytoplasmic and surface-associated urease in survival in acid. Previous cryoimmunolocalization studies in our laboratory have demonstrated that 24-h (fresh sub) preparations of H. pylori grown on blood agar plates possess little or no surface-associated urease; in contrast, 72-h (fresh and repeat sub) preparations demonstrate significant amounts of surface-associated and extracellular urease (38). We hypothesized that this difference in distribution of surface-associated urease would alter the survival of H. pylori exposed to acid in the presence of urea. Freshly subcultured (24 h) H. pylori 84-183 exposed to pH 2 for 30 min in the presence of 5 mM urea did not survive (Fig. 4). In marked contrast, exposure of 72-h fresh sub (Fig. 4) and 72-h repeat sub (Fig. 1) cultures of H. pylori 84-183 to pH 2 plus 5 mM urea did not significantly reduce bacterial viability.
|
Ultrastructural localization of urease antigen in E. coli SE5000(pHP808/pUEF202). Colloidal gold particles representing the localization of urease were located exclusively within the cytoplasm of E. coli SE5000(pHP808/pUEF202) (Fig. 5A), at a density similar to that observed in cross-sections of H. pylori 84-183 (Fig. 5B). Immunolabeling of E. coli SE5000 (which does not carry urease genes) was not observed when antiurease was used as the primary antibody (data not shown) or when preimmune ascites fluid was substituted for the primary antibody during immunolabelling of E. coli SE5000(pHP808/pUEF202) (Fig. 5C).
|
Survival of E. coli expressing cytoplasmic H. pylori urease activity. E. coli SE5000(pHP808/pUEF202), which carries the H. pylori urease gene cluster and nixA (encodes Ni2+ transport protein), expresses cytoplasmic urease activity at levels similar to those in wild-type H. pylori (31) and survived minimally upon exposure to pH 2 for 30 min in the presence of 5 to 50 mM urea (Fig. 6). In the presence of 50 mM urea (pH 2 for 30 min), survival was reduced 6 logs compared with survival of the same strain in saline (pH 7.2) (Fig. 6). At pH 2 for 30 min in the absence of urea, there was no survival. E. coli SE5000(pHP808), E. coli SE5000(pUEF202), and E. coli SE5000 did not survive at pH 2 for 30 min, even with the addition of 50 mM urea (data not shown).
|
Specific urease activity of bacterial preparations. Specific urease activity data are summarized as follows. The specific urease activities of H. pylori (24-h fresh sub), H. pylori (72-h repeat sub), P. mirabilis ATCC 7002, and E. coli SE5000(pHP808/pUEF202) were 4.5 ± 0.35, 16.0 ± 1.9, 0.27 ± 0.04, and 11.6 ± 1.9 µmol of urea per min per mg of protein, respectively (means ± standard errors [n = 3]). The specific urease activity of French press lysates of 72-h repeat sub cultures of H. pylori 84-183 was 2.8 to 3.6 times greater than that in corresponding preparations of 24-h fresh sub bacteria. The specific urease activity of lysates of E. coli SE5000(pHP808/pUEF202) grown in M-9 medium containing 1 µM NiCl for 5 h to induce urease activity was similar to that measured in lysates of H. pylori 84-183 (72-h repeat sub). The specific urease activity of P. mirabilis ATCC 7002 lysates was very low compared with that of H. pylori 84-183 or the recombinant E. coli SE5000(pHP808/pUEF202). The specific urease activities of E. coli SE5000(pHP808), E. coli SE5000(pUEF202), and E. coli SE5000 were not determined, but have been shown previously to be negligible (21, 31).
| |
DISCUSSION |
|---|
|
|
|---|
A variety of evidence suggests that urease activity is essential for initiating colonization of the stomach of animal models by Helicobacter spp. (1, 12-14, 41). Urease is a common taxonomic characteristic among bacteria; in general, however, the enzyme is restricted to the cytoplasmic compartment (reviewed in references 32 and 33). In contrast, H. pylori is unique in possessing both cytoplasmic and surface-associated urease (5, 8, 11, 38). Using cryoimmunolocalization techniques, we have previously demonstrated that urease is located strictly within the cytoplasm of freshly subcultured, early-log-phase H. pylori (38). However, at the end of the log phase, a significant fraction of the enzyme becomes surface associated or extracellular in distribution. Using similar techniques, we have demonstrated that a significant fraction (~30%) of urease is also associated with the surface of H. pylori in vivo (11). Both the surface-associated (or extracellular) and cytoplasmic forms of urease exhibit enzyme activity (38).
In the present study, we sought to determine the contribution of surface-associated and/or extracellular urease to acid resistance of H. pylori. We observed that H. pylori cells with surface-associated and/or extracellular and cytoplasmic urease activity survived in an acid environment, but only when urea was present at 5 mM, thus confirming observations of previous investigators (25, 27). In contrast, H. pylori cells with primarily cytoplasmic urease activity (24-h fresh sub and 72-h fresh sub cultures treated with 1 µM flurofamide) were unable to survive when exposed to acid in the presence of urea (5 mM). Similarly, E. coli cells carrying the H. pylori urease gene cluster and nixA (which encodes the Ni2+ transport protein), which expresses urease strictly within the cytoplasmic compartment, at activity levels similar to those in wild-type H. pylori (3, 31), survived minimally at urea concentrations of 5 to 50 mM.
The present study demonstrates that inhibition of surface-associated and/or extracellular urease activity in whole cells of H. pylori by flurofamide occurs within 10 min; thereafter, the relative amount of enzyme inhibition by 1 µM flurofamide does not increase significantly for up to 60 min. These results support the notion that flurofamide (1 µM) either does not diffuse or diffuses slowly across the cell membranes of H. pylori, as described previously (38), and thus for exposures limited to 30 min would be expected to inhibit surface-associated and/or extracellular urease activity almost exclusively. In contrast, acetohydroxamic acid reduces urease activity in whole cells almost completely within 10 min, demonstrating its ability to diffuse across the membranes of H. pylori (30), resulting in inhibition of both cytoplasmic and surface-associated and/or extracellular urease activity.
Taken together, the results of the present study demonstrate that intracellular urease alone is not sufficient to allow resistance to acid by H. pylori. In contrast, Scott and colleagues have proposed that intracellular urease is activated at low external pH and that it is the intracellular urease activity which is responsible for allowing resistance to external acid (39). The latter authors have confirmed two important observations from our previous work (11, 38). First, external urease is produced by lysis of H. pylori (39). Second, at a concentration of 1 µM, which is 17 times the IC50, flurofamide diffuses slowly, if at all, across the membranes of H. pylori (39). However, the latter authors have not used 1 µM flurofamide to selectively inhibit surface associated or extracellular urease activity, as we have done in the present experiments. A further distinction between these two studies is that different assays were used to assess the viability of H. pylori upon exposure to acid. While Scott et al. assessed proton motive force for short intervals in response to acidified urea as an indicator of bacterial viability (39), we have opted to measure viability directly by using methods established by previous investigators. One possible explanation for the contrasting conclusions of these two studies is that association with the outer membrane of H. pylori protects urease from inactivation by acid, although free urease is inactivated at low pH (2, 28). Such a protective niche would be accessible to urease inhibitors such as flurofamide. Scott et al. (39) have assumed that surface-associated urease is inactivated upon exposure to acid (similar to free urease), but they have not directly tested this assumption. Development of an autolysis-deficient mutant of H. pylori, in which urease is presumably located strictly within the cytoplasmic compartment, would be helpful to resolve discrepancies between the present study and that of Scott et al. (39).
Recent work by Vanet and Labigne has confirmed our earlier observation
that urease is present in the cytoplasm and in the extracellular
compartment of H. pylori cultures (42). However, the latter investigators propose that specific secretion of urease occurs either by ABC (16) or by type III (22)
secretion systems. If a secretion system for H. pylori
urease were to exist, it would have to meet a variety of unique
requirements, as we have outlined previously (38).
Furthermore, the observation that the UreA subunit is "secreted" at
a much higher rate than is the UreB subunit is not supported by the
observations of Scott et al. (39) and is not compatible with
specific secretion of urease, which is composed of equimolar amounts of
UreA and UreB subunits (8, 15, 19). Another important aspect
of the work reported by Vanet and Labigne (42) is the
proposal that H. pylori possesses a homolog of E. coli
-galactosidase that is restricted to the cytoplasm only.
We are unable to find such a homolog or related proteins by sequence
search of the published genome, by use of chromogenic substrates to
detect E. coli
-galactosidase activity, or by
testing affinity-purified
-galactosidase antiserum, including several monoclonal antibodies, from several commercial suppliers for
cross-reactive peptides. Therefore, further characterization of the
-galactosidase homolog protein that is restricted to the cytoplasm
alone is needed to allow verification of its presence.
Urease activity is not essential for growth of H. pylori on blood agar plates at neutral pH, as evidenced by growth of isogenic urease-negative mutants in culture (17, 37). However, cytoplasmic urease may function in the acquisition of nitrogen for protein synthesis, since urea nitrogen, following incubation with H. pylori, ultimately appears in protein (43).
Of interest, although P. mirabilis ATCC 7002 produces urease, it was susceptible to exposure to acid in the presence of urea (5 mM), confirming the results of Marshall et al. (25). There are several possible explanations for this observation. First, the Km for P. mirabilis urease (13 mM urea [23]) is too high for the enzyme to exhibit maximal activity at the low urea concentrations which protect H. pylori against acid in vitro. In contrast, the Km for H. pylori urease is 0.2 to 0.5 mM urea (8, 10, 15, 20). Second, the urease specific activity in P. mirabilis is too low to generate sufficient ammonia to counteract acid (pH 2). Finally, since urease is located strictly within the cytoplasm in P. mirabilis (23), the protection afforded by surface-associated and/or extracellular urease in H. pylori does not occur in P. mirabilis.
Beyond its role in mediating resistance to acid, surface-associated urease may play important roles in the pathogenesis and survival of H. pylori within the stomach. Our observation that a fraction of urease is surface associated in vivo helps to explain how urease can serve as a vaccine in animals and humans, since surface-associated urease would be directly accessible to components of both the humoral and cellular arms of the immune system (11, 38). However, our "altruistic autolysis" model also predicts that a subpopulation of H. pylori that contains only cytoplasmic urease exists deep within the protective gastric mucus or antral pits (11, 38). Because surface-associated urease is not present, such a subpopulation would be expected to evade surveillance by the immune system. Such Helicobacter strains with only cytoplasmic urease would also be expected to evade the effects of urease inhibitors and vaccines administered in vivo. In this regard, in studies with ferrets colonized with H. mustelae, inhibition of urease activity with flurofamide was insufficient to eradicate the bacteria (26). Finally, since urease is reportedly chemotactic for neutrophils (7, 24), continual release of urease may promote the low level of inflammation associated with all H. pylori strains, whether or not they possess other mechanisms for inducing gastric inflammation, such as the cagA pathogenicity island (6).
In this study, survival at pH 2.0 for 30 min is the only criterion assessed as a stringent indicator of acid resistance. The gastric environment presents various pH ranges (from pH 2 to 6) under normal conditions, and the roles of urease molecules present in the surface-associated and cytoplasmic compartments of H. pylori need to be defined under various pH conditions.
A special reference needs to be made to the role of urease in acid resistance in Yersinia enterocolitica. Recently, Young et al. (44) have shown that Y. enterocolitica possess a unique cytoplasmic urease with a pH optimum at 5.5 that is inactive at pH 7.0 but is activated by low pH. This enzyme exhibits full activity at pH 5.5. When extracellular pH is lowered (pH 2) and the cytoplasmic pH in intact bacteria reaches 5.5, urease activity is activated 785-fold over the activity at neutral pH. In the presence of urea, Y. enterocolitica urease is able to impart acid resistance to the bacterium. Furthermore, Y. enterocolitica urease cloned in E. coli is able to confer this ability to resist acid to E. coli. The situation in H. pylori is different. H. pylori urease exhibits a pH optimum of 8.3 and has little or no activity at pH 5.5, and free urease is rapidly inactivated by exposure to pH <5. Our observation that recombinant E. coli expressing H. pylori urease is unable to survive acid treatment also argues against acid activation (analogous to Yersinia) of H. pylori urease.
Eaton and Krakowka (13, 14) have attempted to cocolonize urease-positive H. pylori with an isogenic urease-negative mutant in gnotobiotic piglets. They report that under the conditions used, the urease-negative mutant was unable to colonize piglets, while the urease-positive parent strain was able to colonize. This experiment demonstrates that surface urease alone is not sufficient (presuming that the transfer of urease between two isogenic strains did occur as predicted) to allow survival of bacteria at normal gastric pH, most likely because both cytoplasmic and surface-associated urease activities are needed for acid resistance.
In vitro, free H. pylori urease becomes rapidly inactivated by short exposure to pH <5 (2, 39). Therefore, the fraction of urease that is released by autolysis and remains free is likely to be inactivated and of little consequence in acid resistance. A significant amount of urease activity in the older bacterial preparation is derived from this fraction. Therefore, much of the urease released by autolysis is likely to contribute very little to acid resistance before these urease molecules become irreversibly inactivated because of exposure to low pH. However, the fraction of the urease released by autolysis and associated with the surface may be stabilized and protected from acid denaturation, and it most likely contributes to acid resistance. This model of H. pylori urease localization, activity, and acid resistance is outlined in Fig. 7.
|
In summary, the present studies demonstrate that surface-associated or extracellular urease is essential for acid resistance of H. pylori. Therefore, the process whereby urease becomes associated with the surface of H. pylori, "altruistic autolysis," is an essential mechanism contributing to the pathogenesis of H. pylori. We conclude that surface-associated urease enables H. pylori to adapt to its unique ecological niche in the acidic mammalian stomach.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported in part by Public Health Service grants CA67527 and DK39045 (B.E.D.) and National Institutes of Health grant AI25567 (H.L.T.M.).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Clement J. Zablocki VA Medical Center, Pathology and Laboratory Medicine Service (113), 5000 West National Ave., Milwaukee, WI 53295-1000. Phone: (414) 384-2000 (ext. 1285). Fax: (414) 382-5319. E-mail: Bruce.Dunn{at}med.va.gov.
Editor: V. A. Fischetti
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Andrutis, K. A., J. G. Fox, D. B. Schauer, R. P. Marini, J. C. Murphy, L. Yan, and J. V. Solnick. 1995. Inability of an isogenic urease-negative mutant strain of Helicobacter mustelae to colonize the ferret stomach. Infect. Immun. 63:3722-3725[Abstract]. |
| 2. |
Bauerfeind, P.,
R. Garner,
B. E. Dunn, and H. L. T. Mobley.
1997.
Synthesis and activity of Helicobacter pylori urease and catalase at low pH.
Gut
40:25-30 |
| 3. | Bauerfeind, P., R. M. Garner, and H. L. T. Mobley. 1996. Allelic exchange mutagenesis of nixA in Helicobacter pylori results in reduced nickel transport and urease activity. Infect. Immun. 64:2877-2880[Abstract]. |
| 4. | Blaser, M. J. 1992. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 102:720-727[Medline]. |
| 5. | Bode, G., P. Malfertheiner, G. Lehnhardt, M. Nilius, and H. Ditschuneit. 1993. Ultrastructural localization of urease of Helicobacter pylori. Med. Microbiol. Immunol. 182:233-242[Medline]. |
| 6. |
Censini, S.,
C. Lange,
Z. Y. Xiang,
J. E. Crabtree,
P. Ghiara,
M. Borodovsky,
R. Rappuoli, and A. Covacci.
1996.
Cag, a pathogenicity island of Helicobacter pylori, encodes type i-specific and disease-associated virulence factors.
Proc. Natl. Acad. Sci. USA
93:14648-14653 |
| 7. |
Craig, P. M.,
M. C. Territo,
W. E. Karnes, and J. H. Walsh.
1992.
Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils.
Gut
33:1020-1023 |
| 8. |
Dunn, B. E.,
G. P. Campbell,
G. I. Perez-Perez, and M. J. Blaser.
1990.
Purification and characterization of urease from Helicobacter pylori.
J. Biol. Chem.
265:9464-9469 |
| 9. |
Dunn, B. E.,
G. I. Perez-Perez, and M. J. Blaser.
1989.
Two-dimensional gel electrophoresis and immunoblotting of Campylobacter pylori proteins.
Infect. Immun.
57:1825-1833 |
| 10. |
Dunn, B. E.,
C.-C. Sung,
N. S. Taylor, and J. G. Fox.
1991.
Purification and characterization of Helicobacter mustelae urease.
Infect. Immun.
59:3343-3345 |
| 11. | Dunn, B. E., N. B. Vakil, B. G. Schneider, M. M. Miller, J. B. Zitzer, T. Puetz, and S. H. Phadnis. 1997. Localization of Helicobacter pylori urease and heat shock protein in human gastric biopsies. Infect. Immun. 65:1181-1188[Abstract]. |
| 12. |
Eaton, K. A.,
C. L. Brooks,
D. R. Morgan, and S. Krakowka.
1991.
Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets.
Infect. Immun.
59:2470-2475 |
| 13. |
Eaton, K. A., and S. Krakowka.
1994.
Effect of gastric pH on urease-dependent colonization of gnotobiotic piglets by Helicobacter pylori.
Infect. Immun.
62:3604-3607 |
| 14. | Eaton, K. A., and S. Krakowka. 1995. Avirulent, urease-deficient Helicobacter pylori colonizes gastric epithelial explants ex vivo. Scand. J. Gastroenterol. 30:434-437[Medline]. |
| 15. | Evans, D. J., Jr., D. G. Evans, S. S. Kirkpatrick, and D. Y. Graham. 1991. Characterization of the Helicobacter pylori urease and purification of its subunits. Microb. Pathog. 10:15-26[Medline]. |
| 16. |
Fath, M. J., and R. Kolter.
1993.
ABC transporters: bacterial exporters.
Microbiol. Rev.
57:995-1017 |
| 17. |
Ferrero, R. L.,
V. Cussac,
P. Courcoux, and A. Labigne.
1992.
Construction of isogenic urease-negative mutants of Helicobacter pylori by allelic exchange.
J. Bacteriol.
174:4212-4217 |
| 18. | Forman, D., D. G. Newell, F. Fullerton, J. W. Yarnell, A. R. Stacey, N. Wald, and F. Sitas. 1991. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br. Med. J. 302:1302-1305. |
| 19. | Hawtin, P. R., A. R. Stacey, and D. G. Newell. 1990. Investigation of the structure and localization of the urease of Helicobacter pylori using monoclonal antibodies. J. Gen. Microbiol. 136:1995-2000[Medline]. |
| 20. |
Hu, L.-T., and H. L. T. Mobley.
1990.
Purification and N-terminal analysis of urease from Helicobacter pylori.
Infect. Immun.
58:992-998 |
| 21. |
Hu, L.-T., and H. L. T. Mobley.
1993.
Expression of catalytically active recombinant Helicobacter pylori urease at wild-type levels in Escherichia coli.
Infect. Immun.
61:2563-2569 |
| 22. |
Jarvis, K. G.,
J. A. Giron,
A. E. Jerse,
T. K. McDaniel,
M. S. Donnenberg, and J. B. Kaper.
1995.
Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation.
Proc. Natl. Acad. Sci. USA
92:7996-8000 |
| 23. |
Jones, B. D., and H. L. T. Mobley.
1988.
Proteus mirabilis urease: genetic organization, regulation, and expression of structural genes.
J. Bacteriol.
170:3342-3349 |
| 24. |
Mai, U. E.,
G. I. Perez-Perez,
J. B. Allen,
S. M. Wahl,
M. J. Blaser, and P. D. Smith.
1992.
Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa.
J. Exp. Med.
175:517-525 |
| 25. | Marshall, B. J., L. J. Barrett, C. Prakash, R. W. McCallum, and R. L. Guerrant. 1990. Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology 99:697-702[Medline]. |
| 26. |
McColm, A. A.,
J. A. Bagshaw, and C. F. O'Malley.
1993.
Development of a 14C-urea breath test in ferrets colonized with Helicobacter mustelae: effects of treatment with bismuth, antibiotics and urease inhibitors.
Gut
34:181-186 |
| 27. | McGowan, C. C., T. L. Cover, and M. J. Blaser. 1994. The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism. Gastroenterology 107:1573-1578[Medline]. |
| 28. | Meyer-Rosburg, K., D. R. Scott, D. Rex, K. Melchers, and G. Sachs. 1996. The effect of environmental pH on the proton motive force of Helicobacter pylori. Gastroenterology 111:886-900[Medline]. |
| 29. | Mobley, H. L. T. 1996. The role of Helicobacter pylori urease in the pathogenesis of gastritis and peptic ulceration. Aliment. Pharmacol. Ther. 10(Suppl. 1):57-64. |
| 30. |
Mobley, H. L. T.,
M. J. Cortesia,
L. E. Rosenthal, and B. D. Jones.
1988.
Characterization of urease from Campylobacter pylori.
J. Clin. Microbiol.
26:831-836 |
| 31. | Mobley, H. L., R. M. Garner, and P. Bauerfeind. 1995. Helicobacter pylori nickel-transport gene nixA: synthesis of catalytically active urease in Escherichia coli independent of growth conditions. Mol. Microbiol. 16:97-109[Medline]. |
| 32. |
Mobley, H. L. T., and R. P. Hausinger.
1989.
Microbial ureases: significance, regulation, and molecular characterization.
Microbiol. Rev.
53:85-108 |
| 33. |
Mobley, H. L. T.,
M. D. Island, and R. P. Hausinger.
1995.
Molecular biology of microbial ureases.
Microbiol. Rev.
59:451-480 |
| 34. | Nomura, A., G. N. Stemmermann, P. H. Chyou, I. Kato, G. I. Perez-Perez, and M. J. Blaser. 1991. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N. Engl. J. Med. 325:1132-1136[Abstract]. |
| 35. | Parsonnet, J., G. D. Friedman, D. P. Vandersteen, Y. Chang, J. H. Vogelman, N. Orentreich, and R. K. Sibley. 1991. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325:1127-1131[Abstract]. |
| 36. |
Parsonnet, J.,
S. Hansen,
L. Rodriguez,
A. B. Gelb,
R. A. Warnke,
E. Jellum,
N. Orentreich,
J. H. Vogelman, and G. D. Friedman.
1994.
Helicobacter pylori infection and gastric lymphoma.
N. Engl. J. Med.
330:1267-1271 |
| 37. |
Pérez-Pérez, G. I.,
A. Z. Olivares,
T. L. Cover, and M. J. Blaser.
1992.
Characteristics of Helicobacter pylori variants selected for urease deficiency.
Infect. Immun.
60:3658-3663 |
| 38. | Phadnis, S. H., M. H. Parlow, M. Levy, D. Ilver, C. M. Caulkins, J. B. Connors, and B. E. Dunn. 1996. Surface localization of Helicobacter pylori urease and a heat shock protein homolog requires bacterial autolysis. Infect. Immun. 64:905-912[Abstract]. |
| 39. | Scott, D. R., D. Weeks, C. Hong, S. Postius, K. Melchers, and G. Sachs. 1998. The role of internal urease in acid resistance of Helicobacter pylori. Gastroenterology 114:58-70[Medline]. |
| 40. | Sjostrom, J. E., and H. Larson. 1996. Factors affecting growth and antibiotic susceptibility of H. pylori: effect of pH and urea on the survival of a wild-type strain and a urease-deficient mutant. J. Med. Microbiol. 44:425-433[Abstract]. |
| 41. |
Tsuda, M.,
M. Karita,
M. G. Morshed,
K. Okita, and T. Nakazawa.
1994.
A urease-negative mutant of Helicobacter pylori constructed by allelic exchange mutagenesis lacks the ability to colonize the nude mouse stomach.
Infect. Immun.
62:3586-3589 |
| 42. |
Vanet, A., and A. Labigne.
1998.
Evidence for specific secretion rather than autolysis in the release of some Helicobacter pylori proteins.
Infect. Immun.
66:1023-1027 |
| 43. | Williams, C. L., T. Preston, M. Hossack, C. Slater, and K. E. McColl. 1996. Helicobacter pylori utilises urea for amino acid synthesis. FEMS Immunol. Med. Microbiol. 13:87-94[Medline]. |
| 44. |
Young, G. M.,
D. Amid, and V. L. Miller.
1996.
A bifunctional urease enhances survival of pathogenic Yersinia enterocolitica and Morganella morganii at low pH.
J. Bacteriol.
178:6487-6495 |
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|